DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PIPERACILLIN

« Back to Dashboard

All Clinical Trials for Piperacillin

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003805	Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count	Completed	European Organisation for Research and Treatment of Cancer - EORTC	Phase 3	1997-11-01	RATIONALE: Antibiotic therapy may prevent the development of infection in patients with hematologic cancer and the persistent fever caused by a low white blood cell count. It is not yet known which regimen of antibiotics is most effective in preventing infection in these patients. PURPOSE: Randomized phase III trial to study the effectiveness of piperacillin-tazobactam with or without vancomycin in reducing fever in patients who have leukemia, lymphoma, or Hodgkin's disease.
NCT00044746	Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 4	2000-10-01	Phase IV Open-Label Foot Infection Study is being conducted to generate comparative Efficacy and Safety data in Diabetic Inpatients.
NCT00044759	Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3	1969-12-31	To compare the safety and efficacy of piperacillin/tazobactam (4 g/500 mg) administered intravenously every 6 hours to cefepime (2 g) administered intravenously every 8 hours for the empiric treatment of neutropenic fever in patients with a hematologic malignancy or lymphoma.

Clinical Trial Conditions for Piperacillin

Condition Name

Condition Name for Piperacillin
Intervention	Trials
Urinary Tract Infections	4
Infection	4
Appendicitis	3

Condition MeSH

Condition MeSH for Piperacillin
Intervention	Trials
Infection	24
Communicable Diseases	17
Pneumonia	9

Clinical Trial Locations for Piperacillin

Trials by Country

Trials by Country for Piperacillin
Location	Trials
United States	101
Germany	15
Italy	13
China	13
Canada	12

Trials by US State

Trials by US State for Piperacillin
Location	Trials
Florida	7
California	6
Texas	6
New York	5
Illinois	4

Clinical Trial Progress for Piperacillin

Clinical Trial Phase

Clinical Trial Phase for Piperacillin
Clinical Trial Phase	Trials
Phase 4	28
Phase 3	22
Phase 2/Phase 3	5

Clinical Trial Status

Clinical Trial Status for Piperacillin
Clinical Trial Phase	Trials
Completed	34
Recruiting	19
Not yet recruiting	10

Clinical Trial Sponsors for Piperacillin

Sponsor Name

Sponsor Name for Piperacillin
Sponsor	Trials
Wyeth is now a wholly owned subsidiary of Pfizer	9
Merck Sharp & Dohme Corp.	8
M.D. Anderson Cancer Center	4

Sponsor Type

Sponsor Type for Piperacillin
Sponsor	Trials
Other	110
Industry	37
U.S. Fed	1